Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various… Read more
Prestige Consumer Healthcare Inc (PBV) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.031x
Based on the latest financial reports, Prestige Consumer Healthcare Inc (PBV) has a cash flow conversion efficiency ratio of 0.031x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€57.49 Million) by net assets (€1.82 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Prestige Consumer Healthcare Inc - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Prestige Consumer Healthcare Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Prestige Consumer Healthcare Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Prestige Consumer Healthcare Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ningbo Sanxing Medical Electric Co Ltd
SHG:601567
|
0.043x |
|
Sulzer Ltd
PINK:SULZF
|
0.070x |
|
Tav Havalimanlari Holding AS
PINK:TAVHY
|
0.055x |
|
Silicon Motion Technology Corporation
F:S9M
|
0.032x |
|
L&T Finance Limited
NSE:LTF
|
N/A |
|
Alupar Investimento SA
SA:ALUP11
|
0.039x |
|
Kokuyo Co., Ltd.
PINK:KUKYF
|
0.073x |
|
Mineral Res
PINK:MALRY
|
0.205x |
Annual Cash Flow Conversion Efficiency for Prestige Consumer Healthcare Inc (2014–2025)
The table below shows the annual cash flow conversion efficiency of Prestige Consumer Healthcare Inc from 2014 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | €1.83 Billion | €251.51 Million | 0.137x | -8.86% |
| 2024-03-31 | €1.66 Billion | €248.93 Million | 0.150x | -5.26% |
| 2023-03-31 | €1.45 Billion | €229.72 Million | 0.159x | -3.65% |
| 2022-03-31 | €1.58 Billion | €259.92 Million | 0.165x | -5.02% |
| 2021-03-31 | €1.36 Billion | €235.61 Million | 0.173x | -6.45% |
| 2020-03-31 | €1.17 Billion | €217.12 Million | 0.185x | +7.35% |
| 2019-03-31 | €1.10 Billion | €189.28 Million | 0.173x | -3.11% |
| 2018-03-31 | €1.18 Billion | €210.11 Million | 0.178x | -1.37% |
| 2017-03-31 | €822.55 Million | €148.67 Million | 0.181x | -23.69% |
| 2016-03-31 | €744.34 Million | €176.31 Million | 0.237x | -4.86% |
| 2015-03-31 | €627.62 Million | €156.25 Million | 0.249x | +25.70% |
| 2014-03-31 | €563.36 Million | €111.58 Million | 0.198x | -- |